Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr 11:2022:8487737.
doi: 10.1155/2022/8487737. eCollection 2022.

Cushing Syndrome in a Pediatric Patient with Topical Steroid Overuse

Sandip Kuikel  1 , Sunil Aryal  1 , Rupesh Shingh Basnyat  1 , Suman Rimal  2
Affiliations
Case Reports

Cushing Syndrome in a Pediatric Patient with Topical Steroid Overuse

Sandip Kuikel et al. Case Rep Endocrinol. .

Abstract

Cushing syndrome is a state of hypercortisolism from exogenous or endogenous exposure to glucocorticoids resulting in various clinical manifestations. In this case report, we present a case of a 15-month-old child who presented with cushingoid facies due to over-the-counter misuse of a very potent topical steroid (clobetasol 0.05%) for suspected scabies. Laboratory measurement of urinary free cortisol level was low, and 8 : 00 am basal cortisol level was measured, which was decreased, which confirmed the diagnosis of Cushing syndrome due to exogenous source. Over-the-counter topical steroids should not be used, and one should always consult a registered medical practitioner before using such products. Physicians when prescribing topical steroids should warn patients about the potential side effects of prolonged use of topical steroids.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Moon facies of the child.
Figure 2
Figure 2
Very potent topical steroid used by the patient.
See this image and copyright information in PMC

References

    1. Lacroix A., Feelders R. A., Stratakis C. A., Nieman L. K. Cushing’s syndrome. The Lancet . 2015;386(9996):913–927. doi: 10.1016/s0140-6736(14)61375-1. - DOI - PubMed
    1. Nieman L. K. Cushing’s syndrome: update on signs, symptoms and biochemical screening. European Journal of Endocrinology . 2015;173(4):M33–M38. doi: 10.1530/eje-15-0464. - DOI - PMC - PubMed
    1. Sharma S. T., Nieman L. K., Feelders R. A. Cushing’s syndrome: epidemiology and developments in disease management. Clinical Epidemiology . 2015;7:281–293. - PMC - PubMed
    1. Stratakis C. A. Cushing syndrome in pediatrics. Endocrinology and Metabolism Clinics of North America . 2012;41(4):793–803. doi: 10.1016/j.ecl.2012.08.002. - DOI - PMC - PubMed
    1. Manubolu S., Nwosu O. Exogenous Cushing’s syndrome secondary to intermittent high dose oral prednisone for presumed asthma exacerbations in the setting of multiple emergency department visits. Journal of Clinical and Translational Endocrinology: Case Reports . 2017;6:4–8. doi: 10.1016/j.jecr.2017.07.001. - DOI

Publication types

LinkOut - more resources